Clinical Trial Update: Atorvastatin in Relapsing-Remitting Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 trial testing atorvastatin for relapsing-remitting multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Lipitor (atorvastatin) (atorvastatin)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Relapsing Remitting Multiple Sclerosis | Phase 2 | Status: COMPLETED